ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.

Standard

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. / Schmoll, H J; Van Cutsem, E; Stein, Alexander; Valentini, V; Glimelius, B; Haustermans, K; Nordlinger, B; van de Velde, C J; Balmana, J; Regula, J; Nagtegaal, I D; Beets-Tan, R G; Arnold, D; Ciardiello, F; Hoff, P; Kerr, D; Köhne, C H; Labianca, R; Price, T; Scheithauer, W; Sobrero, A; Tabernero, J; Aderka, D; Barroso, S; Bodoky, G; Douillard, J Y; El Ghazaly, H; Gallardo, J; Garin, A; Glynne-Jones, R; Jordan, K; Meshcheryakov, A; Papamichail, D; Pfeiffer, P; Souglakos, I; Turhal, S; Cervantes, A.

In: ANN ONCOL, Vol. 23, No. 10, 10, 2012, p. 2479-2516.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Schmoll, HJ, Van Cutsem, E, Stein, A, Valentini, V, Glimelius, B, Haustermans, K, Nordlinger, B, van de Velde, CJ, Balmana, J, Regula, J, Nagtegaal, ID, Beets-Tan, RG, Arnold, D, Ciardiello, F, Hoff, P, Kerr, D, Köhne, CH, Labianca, R, Price, T, Scheithauer, W, Sobrero, A, Tabernero, J, Aderka, D, Barroso, S, Bodoky, G, Douillard, JY, El Ghazaly, H, Gallardo, J, Garin, A, Glynne-Jones, R, Jordan, K, Meshcheryakov, A, Papamichail, D, Pfeiffer, P, Souglakos, I, Turhal, S & Cervantes, A 2012, 'ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.', ANN ONCOL, vol. 23, no. 10, 10, pp. 2479-2516. <http://www.ncbi.nlm.nih.gov/pubmed/23012255?dopt=Citation>

APA

Schmoll, H. J., Van Cutsem, E., Stein, A., Valentini, V., Glimelius, B., Haustermans, K., Nordlinger, B., van de Velde, C. J., Balmana, J., Regula, J., Nagtegaal, I. D., Beets-Tan, R. G., Arnold, D., Ciardiello, F., Hoff, P., Kerr, D., Köhne, C. H., Labianca, R., Price, T., ... Cervantes, A. (2012). ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. ANN ONCOL, 23(10), 2479-2516. [10]. http://www.ncbi.nlm.nih.gov/pubmed/23012255?dopt=Citation

Vancouver

Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K et al. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. ANN ONCOL. 2012;23(10):2479-2516. 10.

Bibtex

@article{b7fb22c76c9a4ae3885d6f7cae6ec113,
title = "ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.",
abstract = "Colorectal cancer (CRC) is the most common tumour type in both sexes combined in Western countries. Although screening programmes including the implementation of faecal occult blood test and colonoscopy might be able to reduce mortality by removing precursor lesions and by making diagnosis at an earlier stage, the burden of disease and mortality is still high. Improvement of diagnostic and treatment options increased staging accuracy, functional outcome for early stages as well as survival. Although high quality surgery is still the mainstay of curative treatment, the management of CRC must be a multi-modal approach performed by an experienced multi-disciplinary expert team. Optimal choice of the individual treatment modality according to disease localization and extent, tumour biology and patient factors is able to maintain quality of life, enables long-term survival and even cure in selected patients by a combination of chemotherapy and surgery. Treatment decisions must be based on the available evidence, which has been the basis for this consensus conference-based guideline delivering a clear proposal for diagnostic and treatment measures in each stage of rectal and colon cancer and the individual clinical situations. This ESMO guideline is recommended to be used as the basis for treatment and management decisions.",
keywords = "Humans, Prognosis, Patient Care Team, *Decision Making, Counseling, *Individualized Medicine, Colorectal Neoplasms/diagnosis/epidemiology/*therapy, Humans, Prognosis, Patient Care Team, *Decision Making, Counseling, *Individualized Medicine, Colorectal Neoplasms/diagnosis/epidemiology/*therapy",
author = "Schmoll, {H J} and {Van Cutsem}, E and Alexander Stein and V Valentini and B Glimelius and K Haustermans and B Nordlinger and {van de Velde}, {C J} and J Balmana and J Regula and Nagtegaal, {I D} and Beets-Tan, {R G} and D Arnold and F Ciardiello and P Hoff and D Kerr and K{\"o}hne, {C H} and R Labianca and T Price and W Scheithauer and A Sobrero and J Tabernero and D Aderka and S Barroso and G Bodoky and Douillard, {J Y} and {El Ghazaly}, H and J Gallardo and A Garin and R Glynne-Jones and K Jordan and A Meshcheryakov and D Papamichail and P Pfeiffer and I Souglakos and S Turhal and A Cervantes",
year = "2012",
language = "English",
volume = "23",
pages = "2479--2516",
journal = "ANN ONCOL",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "10",

}

RIS

TY - JOUR

T1 - ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.

AU - Schmoll, H J

AU - Van Cutsem, E

AU - Stein, Alexander

AU - Valentini, V

AU - Glimelius, B

AU - Haustermans, K

AU - Nordlinger, B

AU - van de Velde, C J

AU - Balmana, J

AU - Regula, J

AU - Nagtegaal, I D

AU - Beets-Tan, R G

AU - Arnold, D

AU - Ciardiello, F

AU - Hoff, P

AU - Kerr, D

AU - Köhne, C H

AU - Labianca, R

AU - Price, T

AU - Scheithauer, W

AU - Sobrero, A

AU - Tabernero, J

AU - Aderka, D

AU - Barroso, S

AU - Bodoky, G

AU - Douillard, J Y

AU - El Ghazaly, H

AU - Gallardo, J

AU - Garin, A

AU - Glynne-Jones, R

AU - Jordan, K

AU - Meshcheryakov, A

AU - Papamichail, D

AU - Pfeiffer, P

AU - Souglakos, I

AU - Turhal, S

AU - Cervantes, A

PY - 2012

Y1 - 2012

N2 - Colorectal cancer (CRC) is the most common tumour type in both sexes combined in Western countries. Although screening programmes including the implementation of faecal occult blood test and colonoscopy might be able to reduce mortality by removing precursor lesions and by making diagnosis at an earlier stage, the burden of disease and mortality is still high. Improvement of diagnostic and treatment options increased staging accuracy, functional outcome for early stages as well as survival. Although high quality surgery is still the mainstay of curative treatment, the management of CRC must be a multi-modal approach performed by an experienced multi-disciplinary expert team. Optimal choice of the individual treatment modality according to disease localization and extent, tumour biology and patient factors is able to maintain quality of life, enables long-term survival and even cure in selected patients by a combination of chemotherapy and surgery. Treatment decisions must be based on the available evidence, which has been the basis for this consensus conference-based guideline delivering a clear proposal for diagnostic and treatment measures in each stage of rectal and colon cancer and the individual clinical situations. This ESMO guideline is recommended to be used as the basis for treatment and management decisions.

AB - Colorectal cancer (CRC) is the most common tumour type in both sexes combined in Western countries. Although screening programmes including the implementation of faecal occult blood test and colonoscopy might be able to reduce mortality by removing precursor lesions and by making diagnosis at an earlier stage, the burden of disease and mortality is still high. Improvement of diagnostic and treatment options increased staging accuracy, functional outcome for early stages as well as survival. Although high quality surgery is still the mainstay of curative treatment, the management of CRC must be a multi-modal approach performed by an experienced multi-disciplinary expert team. Optimal choice of the individual treatment modality according to disease localization and extent, tumour biology and patient factors is able to maintain quality of life, enables long-term survival and even cure in selected patients by a combination of chemotherapy and surgery. Treatment decisions must be based on the available evidence, which has been the basis for this consensus conference-based guideline delivering a clear proposal for diagnostic and treatment measures in each stage of rectal and colon cancer and the individual clinical situations. This ESMO guideline is recommended to be used as the basis for treatment and management decisions.

KW - Humans

KW - Prognosis

KW - Patient Care Team

KW - Decision Making

KW - Counseling

KW - Individualized Medicine

KW - Colorectal Neoplasms/diagnosis/epidemiology/therapy

KW - Humans

KW - Prognosis

KW - Patient Care Team

KW - Decision Making

KW - Counseling

KW - Individualized Medicine

KW - Colorectal Neoplasms/diagnosis/epidemiology/therapy

M3 - SCORING: Journal article

VL - 23

SP - 2479

EP - 2516

JO - ANN ONCOL

JF - ANN ONCOL

SN - 0923-7534

IS - 10

M1 - 10

ER -